CONCENTRIC ANALGESICS
Concentric Analgesics is developing a portfolio of novel, non-opioid therapeutics that provide pain relief after a single local administration. It is a biotechnology company focused on developing non-opioid therapeutics for the management of acute and chronic pain.
CONCENTRIC ANALGESICS
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2014-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.concentricanalgesics.com
Total Employee:
11+
Status:
Active
Contact:
+1 415 484 7921
Email Addresses:
[email protected]
Total Funding:
103.08 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag Euro JsDelivr
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Lazurite
Lazurite is a biotechnology company that creates the operating room of the future through smart surgical tools.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Current Advisors List
Current Employees Featured
Founder
Investors List
Venrock
Venrock investment in Series B - Concentric Analgesics
Oracle Investment Management Inc.
Oracle Investment Management Inc. investment in Series B - Concentric Analgesics
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series B - Concentric Analgesics
Official Site Inspections
http://www.concentricanalgesics.com Semrush global rank: 9.73 M Semrush visits lastest month: 114
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
